Skip to main content
. 2015 Nov 4;5:16103. doi: 10.1038/srep16103

Figure 2. ROC curve analysis of serum miR-106a and CA19-9 for the diagnosis of CCA form BBDD or healthy controls.

Figure 2

(A) AUC of serum miR-106a for discriminating CCA patients from BBDD patients; (B) AUC of serum miR-106a for discriminating CCA patients from healthy controls; (C) AUC of serum CA19-9 for discriminating CCA patients from BBDD patients; (D) AUC of serum CA19-9 for discriminating CCA patients from healthy controls.